Tapewire

NYSE · USD

CL

COLGATE PALMOLIVE CO

Export transactions ↓
Tapewire entity
2972
SEC CIK
0000021665
Parsed reports
831

Last 12 months

Inside the activity.

0 purchase rows · 15 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202608
Mar 202600
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202604
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 04, 2026 Filed Aug 6, 2026 20:27 UTC
Wallace Noel R.Director · Chairman, President & CEO
Exercise / conversionCommon Stock 161,021 $72.29 $11,640,208.09
Disclosure

SEC source: 0001225208-26-007020 · doc4.xml · nonDerivative · entry 1

Wallace Noel R. · CIK 0001464265 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 523,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:15 UTC GrantCommon Stock 293 $89.45 $26,208.85
Disclosure

SEC source: 0001225208-26-006375 · doc4.xml · nonDerivative · entry 1

NORRINGTON LORRIE M · CIK 0001188898 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,769

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:15 UTC
Newman BrianDirector
GrantCommon Stock 209 $89.45 $18,695.05
Disclosure

SEC source: 0001225208-26-006374 · doc4.xml · nonDerivative · entry 1

Newman Brian · CIK 0001788049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,831

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
July 01, 2026 Filed Jul 2, 2026 20:15 UTC GrantCommon Stock 265 $89.45 $23,704.25
Disclosure

SEC source: 0001225208-26-006373 · doc4.xml · nonDerivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,229

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
June 16, 2026 Filed Jun 17, 2026 20:06 UTC
GRANT SHANECOO, Americas
Tax withholdingCommon Stock 23,347 $90.66 $2,116,639.02
Disclosure

SEC source: 0001225208-26-006098 · doc4.xml · nonDerivative · entry 1

GRANT SHANE · CIK 0001998772 · COO, Americas

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,481

F1 · kind: Withholding of shares for payment of tax liability incident to the vesting of restricted stock units under the issuer's incentive compensation plan.

Read SEC document
May 15, 2026 Filed May 18, 2026 20:06 UTC
Malcolm GregoryEVP and Controller
SaleCommon Stock 2,300 $88.44 $203,412.00
Disclosure

SEC source: 0001225208-26-005447 · doc4.xml · nonDerivative · entry 1

Malcolm Gregory · CIK 0001934254 · EVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,598

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC
Newman BrianDirector
GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005240 · doc4.xml · derivative · entry 3

Newman Brian · CIK 0001788049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC
Newman BrianDirector
GrantCommon Stock 2,075 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005240 · doc4.xml · nonDerivative · entry 1

Newman Brian · CIK 0001788049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,621

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005239 · doc4.xml · derivative · entry 5

Nelson Kimberly A · CIK 0001526285 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantCommon Stock 2,075 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005239 · doc4.xml · nonDerivative · entry 1

Nelson Kimberly A · CIK 0001526285 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,634

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005238 · doc4.xml · derivative · entry 2

HUNDMEJEAN MARTINA · CIK 0001223622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantCommon Stock 2,075 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005238 · doc4.xml · nonDerivative · entry 1

HUNDMEJEAN MARTINA · CIK 0001223622 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,206

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005241 · doc4.xml · derivative · entry 2

NORRINGTON LORRIE M · CIK 0001188898 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantCommon Stock 2,075 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005241 · doc4.xml · nonDerivative · entry 1

NORRINGTON LORRIE M · CIK 0001188898 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,312

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005237 · doc4.xml · derivative · entry 2

HARRIS C MARTIN · CIK 0001236982 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantCommon Stock 1,556 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005237 · doc4.xml · nonDerivative · entry 1

HARRIS C MARTIN · CIK 0001236982 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,517

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005235 · doc4.xml · derivative · entry 3

CAHILL JOHN T · CIK 0001197000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F3 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F4 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantCommon Stock 2,075 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005235 · doc4.xml · nonDerivative · entry 1

CAHILL JOHN T · CIK 0001197000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,216

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC
Edwards LisaDirector
GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005236 · doc4.xml · derivative · entry 2

Edwards Lisa · CIK 0001668250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC
Edwards LisaDirector
GrantCommon Stock 2,075 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005236 · doc4.xml · nonDerivative · entry 1

Edwards Lisa · CIK 0001668250 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,182

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantStock Option (Right to Buy) · Derivative 2,020 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005234 · doc4.xml · derivative · entry 2

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,020

Underlying: Common Stock · 2,020 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:46 UTC GrantCommon Stock 1,383 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005234 · doc4.xml · nonDerivative · entry 1

BOERNER CHRISTOPHER S. · CIK 0001543747 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,383

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:45 UTC GrantStock Option (Right to Buy) · Derivative 2,424 $0.00 Strike: $86.74 $0.00
Disclosure

SEC source: 0001225208-26-005233 · doc4.xml · derivative · entry 3

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,424

Underlying: Common Stock · 2,424 shares

Expires 2034-05-11

F2 · kind: Annual director stock option grant under the issuer's incentive compensation plan.

F3 · derivative.exercise_date: Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Read SEC document
May 11, 2026 Filed May 13, 2026 20:45 UTC GrantCommon Stock 2,075 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-005233 · doc4.xml · nonDerivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,820

F1 · kind: Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.

Read SEC document
May 07, 2026 Filed May 11, 2026 20:05 UTC
Massey SallyChief People Officer
SaleCommon Stock 8,599 $87.41 $751,632.57
Disclosure

SEC source: 0001225208-26-005088 · doc4.xml · nonDerivative · entry 1

Massey Sally · CIK 0001815662 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,785

F1 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $87.36 to $87.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:07 UTC GrantCommon Stock 294 $89.05 $26,180.70
Disclosure

SEC source: 0001225208-26-004364 · doc4.xml · nonDerivative · entry 1

NORRINGTON LORRIE M · CIK 0001188898 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,160

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:05 UTC
Newman BrianDirector
GrantCommon Stock 210 $89.05 $18,700.50
Disclosure

SEC source: 0001225208-26-004362 · doc4.xml · nonDerivative · entry 1

Newman Brian · CIK 0001788049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,534

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:04 UTC GrantCommon Stock 266 $89.05 $23,687.30
Disclosure

SEC source: 0001225208-26-004361 · doc4.xml · nonDerivative · entry 1

BILBREY JOHN P · CIK 0001268386 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,665

F1 · kind: Portion of annual cash retainer deferred to a stock unit account pursuant to the Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:26 UTC
Hazlin JohnChief Growth Officer
Tax withholdingCommon Stock 6,117 $97.10 $593,960.70
Disclosure

SEC source: 0001225208-26-002617 · doc4.xml · nonDerivative · entry 2

Hazlin John · CIK 0002072169 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,422

F2 · kind: Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:26 UTC
Hazlin JohnChief Growth Officer
GrantCommon Stock 12,803 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002617 · doc4.xml · nonDerivative · entry 1

Hazlin John · CIK 0002072169 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,539

F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:18 UTC
Daniels JenniferCLO and Secretary
Tax withholdingCommon Stock 12,351 $97.10 $1,199,282.10
Disclosure

SEC source: 0001225208-26-002616 · doc4.xml · nonDerivative · entry 2

Daniels Jennifer · CIK 0001410523 · CLO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,844

F2 · kind: Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:18 UTC
Daniels JenniferCLO and Secretary
GrantCommon Stock 25,742 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002616 · doc4.xml · nonDerivative · entry 1

Daniels Jennifer · CIK 0001410523 · CLO and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,195

F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:18 UTC
Massey SallyChief Human Resources Officer
Tax withholdingCommon Stock 8,206 $97.10 $796,802.60
Disclosure

SEC source: 0001225208-26-002614 · doc4.xml · nonDerivative · entry 2

Massey Sally · CIK 0001815662 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,384

F2 · kind: Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:18 UTC
Massey SallyChief Human Resources Officer
GrantCommon Stock 16,805 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002614 · doc4.xml · nonDerivative · entry 1

Massey Sally · CIK 0001815662 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,590

F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:18 UTC
Malcolm GregoryEVP and Controller
Tax withholdingCommon Stock 2,260 $97.10 $219,446.00
Disclosure

SEC source: 0001225208-26-002615 · doc4.xml · nonDerivative · entry 2

Malcolm Gregory · CIK 0001934254 · EVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,898

F2 · kind: Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:18 UTC
Malcolm GregoryEVP and Controller
GrantCommon Stock 6,268 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002615 · doc4.xml · nonDerivative · entry 1

Malcolm Gregory · CIK 0001934254 · EVP and Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,158

F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:17 UTC
SUTULA STANLEY J IIIChief Financial Officer
Tax withholdingCommon Stock 19,746 $97.10 $1,917,336.60
Disclosure

SEC source: 0001225208-26-002613 · doc4.xml · nonDerivative · entry 2

SUTULA STANLEY J III · CIK 0001629897 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,320

F2 · kind: Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:17 UTC
SUTULA STANLEY J IIIChief Financial Officer
GrantCommon Stock 38,678 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002613 · doc4.xml · nonDerivative · entry 1

SUTULA STANLEY J III · CIK 0001629897 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,066

F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:16 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
Tax withholdingCommon Stock 13,081 $97.10 $1,270,165.10
Disclosure

SEC source: 0001225208-26-002612 · doc4.xml · nonDerivative · entry 2

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,629

F2 · kind: Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:16 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
GrantCommon Stock 25,742 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002612 · doc4.xml · nonDerivative · entry 1

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,710

F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:16 UTC
Wallace Noel R.Director · Chairman, President & CEO
Tax withholdingCommon Stock 68,252 $97.10 $6,627,269.20
Disclosure

SEC source: 0001225208-26-002611 · doc4.xml · nonDerivative · entry 2

Wallace Noel R. · CIK 0001464265 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 361,921

F2 · kind: Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:16 UTC
Wallace Noel R.Director · Chairman, President & CEO
GrantCommon Stock 136,710 $0.00 $0.00
Disclosure

SEC source: 0001225208-26-002611 · doc4.xml · nonDerivative · entry 1

Wallace Noel R. · CIK 0001464265 · Director · Chairman, President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 430,173

F1 · kind: Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 21:25 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $76.41 $0.00
Disclosure

SEC source: 0001225208-26-001844 · doc4.xml · derivative · entry 8

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,938

Underlying: Common Stock · 15,000 shares

Expires 2028-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F5 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 21:25 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
SaleCommon Stock 15,000 $97.81 $1,467,111.00
Disclosure

SEC source: 0001225208-26-001844 · doc4.xml · nonDerivative · entry 4

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,415

F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

F4 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 12, 2026 Filed Feb 13, 2026 21:25 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
Exercise / conversionCommon Stock 15,000 $76.41 $1,146,150.00
Disclosure

SEC source: 0001225208-26-001844 · doc4.xml · nonDerivative · entry 3

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 21:25 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
Exercise / conversionStock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $76.41 $0.00
Disclosure

SEC source: 0001225208-26-001844 · doc4.xml · derivative · entry 7

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,938

Underlying: Common Stock · 35,000 shares

Expires 2028-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F5 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 21:25 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
SaleCommon Stock 35,000 $94.61 $3,311,325.50
Disclosure

SEC source: 0001225208-26-001844 · doc4.xml · nonDerivative · entry 2

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,415

F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.50 to $94.78 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 11, 2026 Filed Feb 13, 2026 21:25 UTC
Tsourapas PanagiotisCOO, Eur., APac, Afr Eur, Skin
Exercise / conversionCommon Stock 35,000 $76.41 $2,674,350.00
Disclosure

SEC source: 0001225208-26-001844 · doc4.xml · nonDerivative · entry 1

Tsourapas Panagiotis · CIK 0001576945 · COO, Eur., APac, Afr Eur, Skin

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

Read SEC document
February 10, 2026 Filed Feb 12, 2026 21:08 UTC
Hazlin JohnChief Growth Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 20,989 $0.00 Strike: $76.41 $0.00
Disclosure

SEC source: 0001225208-26-001768 · doc4.xml · derivative · entry 4

Hazlin John · CIK 0002072169 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,989 shares

Expires 2028-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Exercise of stock options awarded under the issuer's incentive compensation plan.

F4 · derivative.exercise_date: Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2020 grant date.

Read SEC document
February 10, 2026 Filed Feb 12, 2026 21:08 UTC
Hazlin JohnChief Growth Officer
SaleCommon Stock 20,989 $94.25 $1,978,211.15
Disclosure

SEC source: 0001225208-26-001768 · doc4.xml · nonDerivative · entry 2

Hazlin John · CIK 0002072169 · Chief Growth Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,645

F2 · kind: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

F3 · price: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $94.19 to $94.30 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.